Bradykinin-Induced Vasodilation of Human Coronary Arteries In Vivo: Role of Nitric Oxide and Angiotensin-Converting Enzyme
- 1 July 1997
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 30 (1) , 108-112
- https://doi.org/10.1016/s0735-1097(97)00112-5
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Role of Endogenous Bradykinin in Human Coronary Vasomotor ControlCirculation, 1995
- Bradykinin-Induced Vasodilation Is Impaired at the Atherosclerotic Site but Is Preserved at the Spastic Site of Human Coronary Arteries In VivoCirculation, 1995
- Endothelium dependent vasomotor responses to endogenous agonists are potentiated following ACE inhibition by a bradykinin dependent mechanismCardiovascular Research, 1994
- The L-Arginine-Nitric Oxide PathwayNew England Journal of Medicine, 1993
- Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions.Journal of Clinical Investigation, 1993
- Potentiation of endothelium-dependent relaxations to bradykinin by angiotensin I converting enzyme inhibitors in canine coronary artery involves both endothelium-derived relaxing and hyperpolarizing factors.Circulation Research, 1992
- Mechanism of coronary vasodilation produced by bradykinin.Circulation, 1991
- Angiotensin I converting enzyme and the changes in our concepts through the years. Lewis K. Dahl memorial lecture.Hypertension, 1990
- Rat aortic smooth muscle cells in culture express kallikrein, kininogen, and bradykininase activity.Journal of Clinical Investigation, 1990
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980